Isan Chen
2019
In 2019, Isan Chen earned a total compensation of $3.3M as Executive Vice President and Chief Medical and Development Officer at Mirati Therapeutics, a 92% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $216,550 |
|---|---|
| Option Awards | $2,637,984 |
| Salary | $433,100 |
| Other | $2,500 |
| Total | $3,290,134 |
Chen received $2.6M in option awards, accounting for 80% of the total pay in 2019.
Chen also received $216.6K in non-equity incentive plan, $433.1K in salary and $2.5K in other compensation.
Rankings
In 2019, Isan Chen's compensation ranked 3,708th out of 13,971 executives tracked by ExecPay. In other words, Chen earned more than 73.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,708 out of 13,971 | 74th |
Division Manufacturing | 1,338 out of 5,695 | 77th |
Major group Chemicals And Allied Products | 464 out of 2,194 | 79th |
Industry group Drugs | 389 out of 1,880 | 79th |
Industry Pharmaceutical Preparations | 293 out of 1,392 | 79th |
Pay ratio
| Isan Chen's Pay | $3,290,134 |
|---|---|
| Median Employee's Pay | $588,168 |
| Pay Ratio | 6to 1 |
In 2019, the annual total compensation of Isan Chen was $3,290,134.
The annual total compensation of the median employee at Mirati Therapeutics was $588,168.
The ratio of Isan Chen's pay to the pay of median employee was therefore 6 to one.
Source: SEC filing on April 17, 2020.
Chen's colleagues
We found four more compensation records of executives who worked with Isan Chen at Mirati Therapeutics in 2019.